1. A cost-effectiveness and budget impact analysis of apremilast in patients with psoriasis in the Italian setting. (2nd April 2020) Authors: Barbieri, Marco; Loconsole, F.; Migliore, A.; Capri, S. Journal: Journal of medical economics Issue: Volume 23:Number 4(2020) Page Start: 362 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. AB0455 Impact of one-year treatment with biotechnologic drugs on work disability and activity impairment in patients with rheumatoid arthritis. (12th June 2018) Authors: Manara, M.; Caporali, R.; Gorla, R.; Fusaro, E.; Pellerito, R.; Rocchetta, P.A.; Sarzi Puttini, P.; Capri, S.; Sinigaglia, L. Journal: Annals of the rheumatic diseases Issue: Volume 77(2018)Supplement 2 Page Start: 1389 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗